Synova Health

Synova Health

São Paulo, Brazil· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Synova Health, founded in 2020 and headquartered in São Paulo, Brazil, is a commercial-stage digital health and medical device company focused on chronic disease management. The company develops integrated technology solutions that combine digital platforms with medical devices to support patients managing long-term health conditions. Operating in the rapidly growing Brazilian health-tech market, Synova Health aims to address the significant burden of chronic diseases through accessible, technology-enabled care models.

Chronic Disease ManagementDigital HealthMedical Devices

Technology Platform

Integrated digital health platform combining software-based remote monitoring and patient engagement tools with medical devices for chronic disease management, designed to enable continuous care delivery outside traditional clinical settings.

Opportunities

The rapidly expanding Brazilian digital health market, combined with regulatory tailwinds supporting telemedicine and remote care, presents significant growth opportunities for Synova Health.
The high prevalence of chronic diseases in Brazil's aging population creates sustained demand for integrated management solutions.
Expansion across Latin America and potential integration with Brazil's public healthcare system (SUS) represent additional avenues for scaling impact and revenue.

Risk Factors

Synova Health faces risks from intense competition by multinational medical device companies and funded digital health startups in Brazil.
The evolving ANVISA regulatory landscape for digital health and medical devices could create compliance challenges and market access delays.
Limited public transparency around products, team, and financials may hinder partnership development and investor confidence.

Competitive Landscape

Synova Health competes with multinational medical device companies (Medtronic, Abbott, J&J) that have established chronic disease portfolios in Brazil, as well as emerging Brazilian digital health startups targeting adjacent healthcare segments. The company's differentiation lies in its integrated software-plus-hardware approach specifically designed for the Brazilian market, though detailed product differentiation cannot be assessed from available information.